Lates News

Novo Nordisk: Subjects treated with Zenaglutide, when receiving the highest test dose of 40 mg at week 36, experienced a maximum weight loss of 14.6%. The study showed that compared to placebo, the drug can reduce blood sugar in adults with type 2 diabetes, with up to 89.1% of subjects achieving target levels of glycosylated hemoglobin.